MIAMI--(BUSINESS WIRE)-- #ClinicalTrials--Segal Trials, a South Florida-based clinical research netw...
Related Stocks: TSE:2395,...
Following a complete response letter last year, Satsuma Pharmaceuticals Inc. received U.S. FDA appro...
The FDA approved a new nasal spray for migraines that was developed by Satsuma Pharmaceuticals. Prev...
Atzumi™ (dihydroergotamine(DHE)) nasal powder is the first and only DHE nasal powder for the acute t...